Prime peptides retatrutide is a synthetic peptide with demonstrated hypoglycemic effects. This pharmaceutical intermediate has shown potential in type 2 diabetes research by stimulating insulin secretion while inhibiting glucagon production in a glucose-dependent manner.
Research indicates prime peptides retatrutide may delay gastric emptying, reduce both fasting and postprandial blood glucose concentrations, decrease food intake, and potentially affect weight management in type 2 diabetes models. The white powder form offers excellent stability and solubility characteristics.
Our prime peptides retatrutide is produced under strict GMP conditions with comprehensive quality control including HPLC-MS analysis. Each batch undergoes sterility testing and third-party verification to ensure research-grade purity and consistency.
The product is supplied in sterile vials with tamper-evident packaging. Proper storage at 2-8°C maintains stability throughout the 2-year shelf life. Prime peptides retatrutide demonstrates excellent water solubility at 5mg/mL concentration.
This prime peptides product is intended for research use only, not for human consumption. Researchers can request custom synthesis options with various specifications available.